Nat Clin Pract Oncol. 2006 Dec;3(12):650-1.

Do we have a clinically useful breast cancer risk reduction agent for healthy women?

Parkside Oncology Clinic, 49 Parkside, Wimbledon, London SW19 5NB, UK. hdummer@parkside-hospital.co.uk

Supplemental Content

Review The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women. [J Natl Compr Canc Netw. 2007]
Review The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
Bevers TB. J Natl Compr Canc Netw. 2007 Sep; 5(8):719-24.
Review Breast cancer risk and immune responses in healthy women. [Oncol Nurs Forum. 2006]
Review Breast cancer risk and immune responses in healthy women.
Park NJ, Kang DH. Oncol Nurs Forum. 2006 Nov 27; 33(6):1151-9. Epub 2006 Nov 27.
Review WITHDRAWN: Multi-agent chemotherapy for early breast cancer. [Cochrane Database Syst Rev. 2008]
Review WITHDRAWN: Multi-agent chemotherapy for early breast cancer.
Clarke MJ. Cochrane Database Syst Rev. 2008 Oct 8; (4):CD000487. Epub 2008 Oct 8.
Review Breast cancer risk reduction and counseling: lifestyle, chemoprevention, and surgery. [J Natl Compr Canc Netw. 2007]
Review Breast cancer risk reduction and counseling: lifestyle, chemoprevention, and surgery.
Mahoney MC. J Natl Compr Canc Netw. 2007 Sep; 5(8):702-10.
Review Raloxifene: a review of its use in the prevention of invasive breast cancer. [Drugs. 2008]
Review Raloxifene: a review of its use in the prevention of invasive breast cancer.
Moen MD, Keating GM. Drugs. 2008; 68(14):2059-83.

Do we have a clinically useful breast cancer risk reduction agent for healthy wo...
Do we have a clinically useful breast cancer risk reduction agent for healthy women?
Nat Clin Pract Oncol. 2006 Dec ;3(12):650-1.

PubMed
Genome-wide natural antisense transcription: coupling its regulation to its diff...
Genome-wide natural antisense transcription: coupling its regulation to its different regulatory mechanisms.
EMBO Rep. 2006 Dec ;7(12):1216-22.

PubMed
Innovative approaches to anti-arrhythmic drug therapy.
Innovative approaches to anti-arrhythmic drug therapy.
Nat Rev Drug Discov. 2006 Dec ;5(12):1034-49.

PubMed
Mining the Wnt pathway for cancer therapeutics.
Mining the Wnt pathway for cancer therapeutics.
Nat Rev Drug Discov. 2006 Dec ;5(12):997-1014.

PubMed
Olfactory projections to the hypothalamus.
Olfactory projections to the hypothalamus.
J Comp Neurol. 1991 Apr 15 ;306(3):447-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.